These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27650406)

  • 1. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
    Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL
    Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
    McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
    Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age.
    Kornstein SG; Bliss C; Kando J; Madhoo M
    J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30817099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
    McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI
    Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
    McElroy SL; Hudson J; Ferreira-Cornwell MC; Radewonuk J; Whitaker T; Gasior M
    Neuropsychopharmacology; 2016 Apr; 41(5):1251-60. PubMed ID: 26346638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review.
    Guerdjikova AI; Blom TJ; Mori N; Matthews A; Cummings T; Casuto LL; McElroy SL
    Clin Neuropharmacol; 2019; 42(6):214-216. PubMed ID: 31725476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.
    Ward K; Citrome L
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):229-238. PubMed ID: 29258368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder.
    Yee K; Serrano D; Kando J; McElroy SL
    Qual Life Res; 2019 Dec; 28(12):3385-3394. PubMed ID: 31473907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisdexamfetamine: A Review in Binge Eating Disorder.
    Heo YA; Duggan ST
    CNS Drugs; 2017 Nov; 31(11):1015-1022. PubMed ID: 29134566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder.
    Ichikawa H; Miyajima T; Yamashita Y; Fujiwara M; Fukushi A; Saito K
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):21-31. PubMed ID: 31718254
    [No Abstract]   [Full Text] [Related]  

  • 14. A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder.
    Gasior M; Hudson J; Quintero J; Ferreira-Cornwell MC; Radewonuk J; McElroy SL
    J Clin Psychopharmacol; 2017 Jun; 37(3):315-322. PubMed ID: 28383364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
    McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
    JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.
    Coghill DR; Banaschewski T; Nagy P; Otero IH; Soutullo C; Yan B; Caballero B; Zuddas A
    CNS Drugs; 2017 Jul; 31(7):625-638. PubMed ID: 28667569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder.
    Schneider E; Higgs S; Dourish CT
    Eur Neuropsychopharmacol; 2021 Dec; 53():49-78. PubMed ID: 34461386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder.
    Fleck DE; Eliassen JC; Guerdjikova AI; Mori N; Williams S; Blom TJ; Beckwith T; Tallman MJ; Adler CM; DelBello MP; Strakowski SM; McElroy SL
    Psychiatry Res Neuroimaging; 2019 Apr; 286():53-59. PubMed ID: 30903953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study.
    Schneider E; Martin E; Rotshtein P; Qureshi KL; Chamberlain SR; Spetter MS; Dourish CT; Higgs S
    Transl Psychiatry; 2022 Jan; 12(1):9. PubMed ID: 35013131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.